Hydroxyethylidene diphosphonate (HEDP) was prepared and labeled with rhenium-188. Its lyophilized kit was developed for instant preparing of 188Re-HEDP. 188Re-HEDP showed high focile uptake in normal mice (> 30% ID/g at carrier co-injection) in BABLC/SPF mice. High quality single photon emission computed tomography (SPECT) image of New Zealand rabbit was obtained at 4 h after intravenous injection of 74 MBq radiotracer. The lyophilized HEDP kit affords the new opportunity for routine clinical application in bone metastases therapy.Supported by the National Natural Science Foundation of China,Beijing Natural Science Foundation中国科学引文数据库(CSCD)660302-1-60302-62
Introduction: 188Re is a promising radionuclide for metabolic therapy because of the emission of hi...
Hendrikse, N.H. [Promotor]Heine, R. ter [Copromotor]Klerk, J.M.H. de [Copromotor]Bloemendal, H.J. [C...
Rhenium-188-hydroxyethylidine diphosphonate(188Re-HEDP) is a novel and attractive radiopharmaceutica...
Hydroxyethylidene diphosphonate (HEDP) was prepared and labeled with rhenium-188. Its lyophilized ki...
Systemic use of radiopharmaceuticals is a recognized alternative method for the treatment of pain in...
Radionuclide bone metastases therapy is a major achievement of nuclear medicine. Development of less...
Pentavalent rhenium-188 dimercaptosuccinic acid [Re-188(V)DMSA] is a beta-emitting analogue of Tc-99...
Objectives. The present study was initiated to explore the effects of hydroxyethylidene diphosphonat...
INTRODUCTION: (188)Rhenium-HEDP is an effective bone-targeting therapeutic radiopharmaceutical, for ...
The purpose of this study is to prepare 99mTc-HEDTMP [N-(2-hydroxyethyl) ethlenediamine-1,1,2-tri (m...
Introduction: 188Rhenium-HEDP is an effective bone-targeting therapeutic radiopharmaceutical, for tr...
Rhemium-186-1-hydroxyethylidene-1,1-diphosphonate ( 186Re-HEDP) has been used for the palliation of ...
The nuclear properties of 186gRe make it a useful agent for radionuclide therapy and imaging. The co...
188Re is a beta- (Emax = 2.12 MeV) and gamma (155 keV) emitter. Since its chemistry is similar to th...
used in previous studies for the palliative treatment of meta-static bone pain. However, the kinetic...
Introduction: 188Re is a promising radionuclide for metabolic therapy because of the emission of hi...
Hendrikse, N.H. [Promotor]Heine, R. ter [Copromotor]Klerk, J.M.H. de [Copromotor]Bloemendal, H.J. [C...
Rhenium-188-hydroxyethylidine diphosphonate(188Re-HEDP) is a novel and attractive radiopharmaceutica...
Hydroxyethylidene diphosphonate (HEDP) was prepared and labeled with rhenium-188. Its lyophilized ki...
Systemic use of radiopharmaceuticals is a recognized alternative method for the treatment of pain in...
Radionuclide bone metastases therapy is a major achievement of nuclear medicine. Development of less...
Pentavalent rhenium-188 dimercaptosuccinic acid [Re-188(V)DMSA] is a beta-emitting analogue of Tc-99...
Objectives. The present study was initiated to explore the effects of hydroxyethylidene diphosphonat...
INTRODUCTION: (188)Rhenium-HEDP is an effective bone-targeting therapeutic radiopharmaceutical, for ...
The purpose of this study is to prepare 99mTc-HEDTMP [N-(2-hydroxyethyl) ethlenediamine-1,1,2-tri (m...
Introduction: 188Rhenium-HEDP is an effective bone-targeting therapeutic radiopharmaceutical, for tr...
Rhemium-186-1-hydroxyethylidene-1,1-diphosphonate ( 186Re-HEDP) has been used for the palliation of ...
The nuclear properties of 186gRe make it a useful agent for radionuclide therapy and imaging. The co...
188Re is a beta- (Emax = 2.12 MeV) and gamma (155 keV) emitter. Since its chemistry is similar to th...
used in previous studies for the palliative treatment of meta-static bone pain. However, the kinetic...
Introduction: 188Re is a promising radionuclide for metabolic therapy because of the emission of hi...
Hendrikse, N.H. [Promotor]Heine, R. ter [Copromotor]Klerk, J.M.H. de [Copromotor]Bloemendal, H.J. [C...
Rhenium-188-hydroxyethylidine diphosphonate(188Re-HEDP) is a novel and attractive radiopharmaceutica...